Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women

NACompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 16, 2015

Study Completion Date

September 12, 2024

Conditions
Contraception
Interventions
DEVICE

ESS505 (BAY1454033)

Trial Locations (22)

10032

New York

10467

The Bronx

14004

Córdoba

23507

Norfolk

28801

Asheville

33414

Wellington

45242

Cincinnati

46825

Fort Wayne

47630

Newburgh

48604

Saginaw

55905

Rochester

60004

Columbia

75062

Irving

75208

Dallas

77074

Houston

80045

Aurora

80231

Denver

99204

Spokane

L8L 2X2

Hamilton

S4S 6X3

Regina

8025 AB

Zwolle

08906

L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY